How does CANL's PB Ratio compare to its peers?

Insufficient data to calculate CANL's Price-To-Book Ratio vs. peers for valuation analysis.

How does CANL's PB Ratio compare vs other companies in the US Healthcare Industry?

Insufficient data to calculate CANL's Price-To-Book Ratio vs. industry for valuation analysis.

What is CANL's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate CANL's Price-To-Book Fair Ratio for valuation analysis.

What is the Fair Price of CANL when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Insufficient data to calculate CANL's fair value for valuation analysis.

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

CannLabs (OTCPK:CANL) - Stock Price, News & Analysis

CANL Stock Overview

Provides cannabis testing laboratory services in the United States. More details

CANL fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Latest financial reports are more than a year old

Does not have a meaningful market cap ($942)

Shares are highly illiquid

My Notes

Capture your thoughts, links and company narrative

CannLabs, Inc. Competitors

BIMI Holdings

OTCPK:BIMI

US$1.4k

Motus GI Holdings

OTCPK:MOTS

US$719.0

UpHealth

OTCPK:UPHL

US$3.8k

ThermoGenesis Holdings

OTCPK:THMO

US$4.8k

Price History & Performance

Summary of share price highs, lows and changes for CannLabs
Historical stock prices
Current Share Price	US$0.000001
52 Week High	US$0.04
52 Week Low	US$0.000001
Beta	0
1 Month Change	0%
3 Month Change	-99.00%
1 Year Change	n/a
3 Year Change	-100.00%
5 Year Change	-100.00%
Change since IPO	-100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	CANL	US Healthcare	US Market
7D	0%	-2.6%	0.2%
1Y	n/a	-4.6%	23.1%

Return vs Industry: Insufficient data to determine how CANL performed against the US Healthcare industry.

Return vs Market: Insufficient data to determine how CANL performed against the US Market.

Price Volatility

Is CANL's price volatile compared to industry and market?
CANL volatility
CANL Average Weekly Movement	n/a
Healthcare Industry Average Movement	6.5%
Market Average Movement	5.9%
10% most volatile stocks in US Market	18.3%
10% least volatile stocks in US Market	3.0%

Stable Share Price: CANL's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine CANL's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2010	n/a	Mark Mirken	n/a

CannLabs, Inc. provides cannabis testing laboratory services in the United States. Its testing services include potency testing, residual solvent analysis, microbiological testing, pesticide testing, heavy metals testing, nutrient analysis, terpenes analysis, shelf-life/stability studies, gene expression testing, and genotyping/phenotyping testing. The company also offers data/analytics and consulting, as well as education services.

CannLabs, Inc. Fundamentals Summary

How do CannLabs's earnings and revenue compare to its market cap?
CANL fundamental statistics
Market cap	US$942.00
Earnings (TTM)	-US$1.69m
Revenue (TTM)	US$1.72m

0.0x

P/S Ratio

0.0x

P/E Ratio

Is CANL overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CANL income statement (TTM)
Revenue	US$1.72m
Cost of Revenue	US$1.17m
Gross Profit	US$552.20k
Other Expenses	US$2.24m
Earnings	-US$1.69m

Last Reported Earnings

Mar 31, 2015

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did CANL perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/02/12 04:30
End of Day Share Price	2024/12/17 00:00
Earnings	2015/03/31
Annual Earnings	2014/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

CannLabs, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.